Drug Safety

share

The US Food and Drug Administration (FDA) has approved Merck’s PREVYMIS (letermovir) tablets for oral use and injection...

share

Quotient Clinical announced that it has signed an agreement with Nuformix Technologies Limited (a wholly owned subsidiary of...

share

The Series E funding was supported by existing investors including dievini Hopp Biotech holding, Wellington Partners, AT Impf...

share

Astellas Pharma Inc. and Universal Cells, Inc. announced that Astellas Institute for Regenerative Medicine (“AIRM”) and Universal Cells...

share

AstraZeneca announced that it has entered into an agreement with Aspen Global Incorporated under which AGI will now...

share

Champions Oncology, a company engaged in the development and sale of advanced technology solutions and products to personalize...

share

Teva Pharmaceutical Industries announced the launch of generic Axiron®1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the...

share

A new consortium, led by Oxford BioMedica, will take part in a two-year, £2m project focused on gene...